Abstract
Few developing countries understand the production of medicines as an industrial strategy as Brazil. These countries are usually discouraged to adopt industrial policies for this sector given the associated costs; on the other hand, they are encouraged to promote access to medicines. How can this dilemma be balanced? How can innovations in public policies in Brazil contribute to understan…